Screener
Boston Scientific BSX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
| (in millions, except share and per share data) | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Other long-term liabilities | 2,469 | 2,405 |
| Commitments and contingencies | ||
| Stockholders’ equity | ||
| Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of March 31, 2026 and 1,746,290,165 shares issued as of December 31, 2025 | 17 | 17 |
| Treasury stock, at cost - 263,289,848 shares as of March 31, 2026 and December 31, 2025 | (2,251) | (2,251) |
| Additional paid-in capital | 21,584 | 21,505 |
| Retained earnings | 6,912 | 5,571 |
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Boston Scientific's preferred stock, shares authorized?
- Boston Scientific (BSX) reported preferred stock, shares authorized of 50M in Q1 2026.
- How has Boston Scientific's preferred stock, shares authorized changed year-over-year?
- Boston Scientific's preferred stock, shares authorized decreased by 0.0% year-over-year, from 50M to 50M.
- What is the long-term trend for Boston Scientific's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Boston Scientific's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from 50M to 50M.
Ask your AI about Boston Scientific's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude